Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
Epidemiology and Psychiatric Sciences
|
December 17, 2019
Esketamine for treatment resistant depression: a trick of smoke and mirrors?
C Gastaldon, D Papola, G Ostuzzi, et al.
Epidemiology and Psychiatric Sciences
|
November 23, 2016
Antipsychotic drug exposure and risk of myocardial infarction
C Barbui, C Gastaldon, D Papola, et al.
Pharmacopsychiatry
|
May 20, 2005
Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy
M Percudani, C Barbui, I Fortino, et al.
Pharmacoepidemiology and Drug Safety
|
April 10, 2004
QUALYOP project 2: monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatients
C Barbui, B D'Avanzo, L Frattura, et al.
European Journal of Clinical Pharmacology
|
January 5, 2002
Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database
C Pietraru, C Barbui, L Poggio, et al.
Epidemiology and Psychiatric Sciences
|
December 23, 2016
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base
G Ostuzzi, D Papola, C Gastaldon, et al.
Psychological Medicine
|
July 29, 2014
Pragmatic design in randomized controlled trials
M Purgato, C Barbui, S Stroup, et al.
Acta Psychiatrica Scandinavica
|
December 3, 2013
Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder
A Cipriani, C Barbui, J Rendell, et al.
Acta Psychiatrica Scandinavica
|
April 10, 2002
Determinants of subjective quality of life in patients attending community-based mental health services. The South-Verona Outcome Project 5
M Ruggeri, R Gater, G Bisoffi, et al.
Epidemiology and Psychiatric Sciences
|
May 7, 2016
Implementing a data sharing culture
C Barbui, O Gureje, B Puschner, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
Epidemiology and Psychiatric Sciences
|
December 17, 2019
Esketamine for treatment resistant depression: a trick of smoke and mirrors?
C Gastaldon, D Papola, G Ostuzzi, et al.
Epidemiology and Psychiatric Sciences
|
November 23, 2016
Antipsychotic drug exposure and risk of myocardial infarction
C Barbui, C Gastaldon, D Papola, et al.
Pharmacopsychiatry
|
May 20, 2005
Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy
M Percudani, C Barbui, I Fortino, et al.
Pharmacoepidemiology and Drug Safety
|
April 10, 2004
QUALYOP project 2: monitoring the dismantling of Italian psychiatric hospitals. Psychotropic drug use in 1072 inpatients
C Barbui, B D'Avanzo, L Frattura, et al.
European Journal of Clinical Pharmacology
|
January 5, 2002
Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database
C Pietraru, C Barbui, L Poggio, et al.
Epidemiology and Psychiatric Sciences
|
December 23, 2016
New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base
G Ostuzzi, D Papola, C Gastaldon, et al.
Psychological Medicine
|
July 29, 2014
Pragmatic design in randomized controlled trials
M Purgato, C Barbui, S Stroup, et al.
Acta Psychiatrica Scandinavica
|
December 3, 2013
Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder
A Cipriani, C Barbui, J Rendell, et al.
Acta Psychiatrica Scandinavica
|
April 10, 2002
Determinants of subjective quality of life in patients attending community-based mental health services. The South-Verona Outcome Project 5
M Ruggeri, R Gater, G Bisoffi, et al.
Epidemiology and Psychiatric Sciences
|
May 7, 2016
Implementing a data sharing culture
C Barbui, O Gureje, B Puschner, et al.
Page
of 11